Clinical Trials
2 trialsNCT01122875 2016-11-02
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma
Genentech, Inc.
Phase 1 Completed
NCT01363024 2016-11-02
Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors
Genentech, Inc.
Phase 1 Completed